At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:
Hematology
- Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
- Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
- Understand blood and marrow morphology and hematopathology
- Understand red cell disorders
Hematologic Malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Identify strategies for taking the board examinations
Oncology
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Comprehend the principles of management of gynecologic and other genito-urinary malignancies
- Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Recognize principles of new developments in biologic therapy of cancer
- Contend with complexity of HIV-related malignancies
COURSE OVERVIEW
Hematology Sessions:
- Day 1: Hemoglobinopathies, White Cell Disorders, Bone Marrow Failure and Sickle Cell Disease Overview
- Day 2: Clotting and Bleeding Disorders
- Day 3: TTP, HUS, DIC, HIT, ABO Incompatibility, Hematopoietic Transplantation and Hematologic Complications of Pregnancy
Hematologic Malignancies Sessions:
- Day 4: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS
- Day 5: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms and Pharmacology
Medical Oncology Sessions:
- Day 6: Breast Cancer, Lung Cancer, and Neuro-Oncology
- Day 7: Renal Cell, Prostate, Bladder, Testicular, Ovarian and Endometrial Tumors
- Day 8: GI Oncology, Mesothelioma and Sarcomas